Empowered Funds LLC Boosts Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Empowered Funds LLC raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 23.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,753 shares of the company’s stock after buying an additional 6,291 shares during the quarter. Empowered Funds LLC’s holdings in Bath & Body Works were worth $1,270,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Fifth Third Wealth Advisors LLC grew its holdings in Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after purchasing an additional 324 shares during the period. TD Private Client Wealth LLC grew its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. UMB Bank n.a. increased its holdings in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares during the last quarter. Avior Wealth Management LLC raised its position in shares of Bath & Body Works by 30.3% in the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock worth $76,000 after buying an additional 453 shares during the period. Finally, Golden State Wealth Management LLC acquired a new position in Bath & Body Works in the fourth quarter valued at $26,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of BBWI opened at $36.50 on Monday. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The stock has a 50-day moving average price of $37.63 and a 200 day moving average price of $33.66. The company has a market capitalization of $7.91 billion, a P/E ratio of 8.90, a P/E/G ratio of 0.90 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business’s revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.48 EPS. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s payout ratio is currently 19.51%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on BBWI. Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. Barclays raised their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a report on Tuesday, November 26th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $43.19.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.